Perspective Therapeutics Files 8-K
Ticker: CATX · Form: 8-K · Filed: Sep 2, 2025 · CIK: 728387
Sentiment: neutral
Topics: reporting, corporate-update
TL;DR
Perspective Therapeutics (formerly Isoray) filed an 8-K on Sept 2, 2025. Standard reporting.
AI Summary
Perspective Therapeutics, Inc. filed an 8-K on September 2, 2025, reporting other events and financial statements. The company, formerly known as Isoray, Inc., is incorporated in Delaware and headquartered in Seattle, Washington.
Why It Matters
This filing indicates a routine update or event for Perspective Therapeutics, Inc., providing transparency to investors about the company's operational status and financial reporting.
Risk Assessment
Risk Level: low — This is a routine 8-K filing for corporate reporting and does not appear to contain any significant new risks or material adverse information.
Key Numbers
- 0000728387-25-000006 — Accession Number (Unique identifier for the filing)
- 001-33407 — Commission File Number (SEC file number for the company)
- 41-1458152 — IRS Employer Identification No. (Company's tax identification number)
Key Players & Entities
- Perspective Therapeutics, Inc. (company) — Registrant
- Isoray, Inc. (company) — Former company name
- IsoRay, Inc. (company) — Former company name
- CENTURY PARK PICTURES CORP (company) — Former company name
- September 2, 2025 (date) — Date of report
- 2401 ELLIOTT AVENUE SUITE 320 (address) — Principal Executive Offices
- Seattle, Washington (location) — Principal Executive Offices
FAQ
What is the primary purpose of this 8-K filing?
This 8-K filing is for reporting 'Other Events' and 'Financial Statements and Exhibits' as of September 2, 2025.
What was Perspective Therapeutics, Inc. previously named?
Perspective Therapeutics, Inc. was formerly known as Isoray, Inc. and IsoRay, Inc.
Where is Perspective Therapeutics, Inc. headquartered?
The company's principal executive offices are located at 2401 Elliott Avenue, Suite 320, Seattle, Washington.
When was the report filed?
The report was filed on September 2, 2025.
What is the company's Standard Industrial Classification code?
The company's SIC code is 2834, which corresponds to Pharmaceutical Preparations.
Filing Stats: 413 words · 2 min read · ~1 pages · Grade level 10.6 · Accepted 2025-09-02 07:00:38
Key Financial Figures
- $0.001 — nge on which registered Common Stock, $0.001 par value CATX NYSE American LLC
Filing Documents
- catx-20250902.htm (8-K) — 48KB
- catx-ex99_1.htm (EX-99.1) — 20KB
- catx-ex99_1s1.jpg (GRAPHIC) — 131KB
- catx-ex99_1s2.jpg (GRAPHIC) — 530KB
- catx-ex99_1s3.jpg (GRAPHIC) — 268KB
- catx-ex99_1s4.jpg (GRAPHIC) — 193KB
- catx-ex99_1s5.jpg (GRAPHIC) — 238KB
- catx-ex99_1s6.jpg (GRAPHIC) — 288KB
- catx-ex99_1s7.jpg (GRAPHIC) — 253KB
- catx-ex99_1s8.jpg (GRAPHIC) — 109KB
- catx-ex99_1s9.jpg (GRAPHIC) — 250KB
- catx-ex99_1s10.jpg (GRAPHIC) — 274KB
- catx-ex99_1s11.jpg (GRAPHIC) — 337KB
- catx-ex99_1s12.jpg (GRAPHIC) — 242KB
- catx-ex99_1s13.jpg (GRAPHIC) — 343KB
- catx-ex99_1s14.jpg (GRAPHIC) — 261KB
- catx-ex99_1s15.jpg (GRAPHIC) — 258KB
- catx-ex99_1s16.jpg (GRAPHIC) — 132KB
- catx-ex99_1s17.jpg (GRAPHIC) — 228KB
- catx-ex99_1s18.jpg (GRAPHIC) — 393KB
- catx-ex99_1s19.jpg (GRAPHIC) — 120KB
- catx-ex99_1s20.jpg (GRAPHIC) — 298KB
- catx-ex99_1s21.jpg (GRAPHIC) — 316KB
- catx-ex99_1s22.jpg (GRAPHIC) — 207KB
- catx-ex99_1s23.jpg (GRAPHIC) — 322KB
- catx-ex99_1s24.jpg (GRAPHIC) — 206KB
- catx-ex99_1s25.jpg (GRAPHIC) — 388KB
- catx-ex99_1s26.jpg (GRAPHIC) — 202KB
- catx-ex99_1s27.jpg (GRAPHIC) — 329KB
- catx-ex99_1s28.jpg (GRAPHIC) — 266KB
- catx-ex99_1s29.jpg (GRAPHIC) — 121KB
- catx-ex99_1s30.jpg (GRAPHIC) — 258KB
- catx-ex99_1s31.jpg (GRAPHIC) — 311KB
- catx-ex99_1s32.jpg (GRAPHIC) — 314KB
- catx-ex99_1s33.jpg (GRAPHIC) — 214KB
- catx-ex99_1s34.jpg (GRAPHIC) — 354KB
- catx-ex99_1s35.jpg (GRAPHIC) — 248KB
- catx-ex99_1s36.jpg (GRAPHIC) — 255KB
- catx-ex99_1s37.jpg (GRAPHIC) — 300KB
- catx-ex99_1s38.jpg (GRAPHIC) — 134KB
- catx-ex99_1s39.jpg (GRAPHIC) — 290KB
- catx-ex99_1s40.jpg (GRAPHIC) — 302KB
- catx-ex99_1s41.jpg (GRAPHIC) — 286KB
- catx-ex99_1s42.jpg (GRAPHIC) — 228KB
- catx-ex99_1s43.jpg (GRAPHIC) — 218KB
- catx-ex99_1s44.jpg (GRAPHIC) — 218KB
- catx-ex99_1s45.jpg (GRAPHIC) — 312KB
- catx-ex99_1s46.jpg (GRAPHIC) — 265KB
- catx-ex99_1s47.jpg (GRAPHIC) — 95KB
- catx-ex99_1s48.jpg (GRAPHIC) — 261KB
- catx-ex99_1s49.jpg (GRAPHIC) — 245KB
- catx-ex99_1s50.jpg (GRAPHIC) — 197KB
- catx-ex99_1s51.jpg (GRAPHIC) — 97KB
- catx-ex99_1s52.jpg (GRAPHIC) — 288KB
- catx-ex99_1s53.jpg (GRAPHIC) — 85KB
- catx-ex99_1s54.jpg (GRAPHIC) — 344KB
- catx-ex99_1s55.jpg (GRAPHIC) — 303KB
- catx-ex99_1s56.jpg (GRAPHIC) — 297KB
- catx-ex99_1s57.jpg (GRAPHIC) — 265KB
- catx-ex99_1s58.jpg (GRAPHIC) — 220KB
- catx-ex99_1s59.jpg (GRAPHIC) — 226KB
- catx-ex99_1s60.jpg (GRAPHIC) — 302KB
- catx-ex99_1s61.jpg (GRAPHIC) — 321KB
- catx-ex99_1s62.jpg (GRAPHIC) — 239KB
- catx-ex99_1s63.jpg (GRAPHIC) — 305KB
- 0000728387-25-000006.txt ( ) — 22349KB
- catx-20250902.xsd (EX-101.SCH) — 26KB
- catx-20250902_htm.xml (XML) — 5KB
01 Other Events
Item 8.01 Other Events. On September 2, 2025, Perspective Therapeutics, Inc. updated its corporate presentation. A copy of the presentation is filed as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated by reference into this Item 8.01.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Corporate Presentation . 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. PERSPECTIVE THERAPEUTICS, INC. Date: September 2, 2025 By: /s/ Juan Graham Juan Graham Chief Financial Officer